Can docetaxel therapy improve overall survival from primary therapy compared with androgen-deprivation therapy alone in Japanese patients with castration-resistant prostate cancer? A multi-institutional cooperative study (Q45137439)
Jump to navigation
Jump to search
scientific article published on 3 November 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Can docetaxel therapy improve overall survival from primary therapy compared with androgen-deprivation therapy alone in Japanese patients with castration-resistant prostate cancer? A multi-institutional cooperative study |
scientific article published on 3 November 2011 |
Statements
1 reference
Can docetaxel therapy improve overall survival from primary therapy compared with androgen-deprivation therapy alone in Japanese patients with castration-resistant prostate cancer? A multi-institutional cooperative study (English)
1 reference
Tomoyuki Shimabukuro
1 reference
Shigeru Sakano
1 reference
Kenji Matsuda
1 reference
Yoriaki Kamiryo
1 reference
Norio Yamamoto
1 reference
Yoshitaka Kaneda
1 reference
Takahito Nasu
1 reference
Yoshikazu Baba
1 reference
Akinobu Suga
1 reference
Mitsutaka Yamamoto
1 reference
Akihiko Aoki
1 reference
Kimio Takai
1 reference
Satoru Yoshihiro
1 reference
Motohiko Konishi
1 reference
Katsuhiko Imoto
1 reference
Hideyasu Matsuyama
1 reference
3 November 2011
1 reference
1 reference
18
1 reference
1
1 reference
62-67
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference